MW
VRTX icon

Marble Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Marble Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
477
+10
+2% +$4.43K 0.04% 218
2026
Q1 		$208K Sell
467
-398
-46% -$186K 0.04% 214
2025
Q4 		$392K Buy
+865
New +$373K 0.05% 200

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Marble Wealth's VRTX Position: Q2 2026 in Review

Marble Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 2.1% in Q2 2026, buying an estimated $4.43K and bringing the position to 477 shares worth $237K. The position accounts for 0.04% of the portfolio, ranked #218.

Marble Wealth first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $392K in Q4 2025. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Marble Wealth held 477 shares of Vertex Pharmaceuticals worth $237K as of Q2 2026.
  • Marble Wealth bought 10 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.43K.
  • Vertex Pharmaceuticals made up 0.04% of Marble Wealth's portfolio in Q2 2026, its #218 holding.
  • Marble Wealth first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Marble Wealth's Vertex Pharmaceuticals position peaked at $392K in Q4 2025.
  • 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Marble Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.